Data Analysis Enables Identification of Neighborhood-Specific Risk Factors for Preterm Birth
Through computer analysis of geographical information, researchers believe they can provide optimal and targeted strategies for preventing preterm birth and they have data from a study of
"By identifying risk factors for each area that are potentially modifiable, we are able to begin to also identify the right intervention for that specific population of mothers, says Andrew South, MD, a neonatologist at Cincinnati Childrens and senior author of the study. "The list of risk factors that we used in this study is consistent with what is in published literature, suggesting that preterm birth in
South will present his study at 1:45 p.m. Eastern time Saturday, May 1, at the annual meeting of the Pediatric Academic Societies in
The Cincinnati Childrens
Five distinct areas were identified for further analysis. All births in the five areas were further analyzed to determine differences in demographics and potentially modifiable risk factors for preterm birth, including previous preterm birth, chronic or gestational hypertension, education level, diabetes, short inter-pregnancy interval, smoking, advanced maternal age and low pre-pregnancy weight.
The researchers used Geographic Information System (GIS) techniques to determine the proportion of preterm births for geographical points throughout the county. In doing this, they removed artificial geopolitical boundaries in favor of allowing the natural disease pattern to identify areas for further evaluation, according to South.
"While use of political boundaries, such as counties, may be useful in defining the scope of a problem, it is less useful from a public health standpoint because it does not allow for precise identification of specific populations at risk for a poor outcome, he says.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.